|Trial Design||Non-randomized controlled trial|
|Trial Length||1-6 months|
|Number of Subjects||23|
|Age Range||30-44, 45-64|
This study is a safety analysis of a previous study[PMID: 29951594]. It evaluated the occurrence of adverse events such GI and neurological issues, symptoms of eating disorders, and problematic eating behavior.